Speech-Language Pathologists in Brush, CO Accepting Medicare
6 Speech-Language Pathologists found. Showing 1 - 6
 Gregory Engbrecht Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 122 Hospital Rd, Brush, CO 80723 Phone: 970-842-2861 |
 Kayla Hood, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 122 Hospital Rd, Brush, CO 80723 Phone: 970-842-2861 |
Jackie Nelson, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2200 Edison St, Brush, CO 80723 Phone: 210-378-5763 |
Juhee Yi Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2200 Edison St, Brush, CO 80723 Phone: 970-842-2825 |
Coral Noble, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 122 Hospital Rd, Brush, CO 80723 Phone: 970-842-2861 |
Leslie Elaine Shaver Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15949 County Road 29.5, Brush, CO 80723 Phone: 970-768-3458 |
News Archive
A person's socioeconomic status can help predict heart failure mortality
Heart failure is a medical condition that results when the heart muscle is not strong enough to effectively circulate blood.
CE mark approves Vitrolife's SpermFreeze Solution
SpermFreeze Solution, which is used for freeze storage of sperm, has obtained a CE mark and is thereby approved for sales within the European Economic Area.
Activation of glial cells causes inflammation in the brain of fibromyalgia patients
The causes of the difficult-to-treat pain syndrome fibromyalgia are largely unknown. Using PET brain imaging, researchers at Karolinska Institutet and Harvard University have now shown that glial cells - the central nervous system's immune cells - are activated in the brains of patients with fibromyalgia. The finding opens the way for new therapies
Air pollution effects Cystic Fibrosis Sufferers
University of Washington (UW) researchers have shown for the first time that air pollution has adverse effects on people with cystic fibrosis (CF). The research results are published in the April 1 edition of the American Journal of Respiratory and Critical Care Medicine.
FDA approves novel device to treat symptoms associated with advanced heart failure
The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization therapy.
› Verified 5 days ago
Speech-Language Pathologists
Chiropractors
Occupational Therapists
Optometrists
Physical Therapists